Secor Capital Advisors’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-833
Closed -$146K 574
2017
Q2
$146K Sell
833
-2,383
-74% -$339K 0.01% 433
2017
Q1
$386K Sell
3,216
-412
-11% -$42.9K 0.04% 372
2016
Q4
$354K Sell
3,628
-115
-3% -$10.5K 0.04% 389
2016
Q3
$351K Buy
3,743
+123
+3% +$12.3K 0.04% 415
2016
Q2
$389K Buy
3,620
+1,136
+46% +$133K 0.05% 444
2016
Q1
$298K Buy
2,484
+90
+4% +$9.45K 0.04% 441
2015
Q4
$285K Buy
2,394
+593
+33% +$76.5K 0.08% 394
2015
Q3
$307K Buy
1,801
+242
+16% +$46.4K 0.1% 347
2015
Q2
$302K Buy
+1,559
New +$289K 0.11% 298

Other funds holding SRGA

Secor Capital Advisors's SRGA Position: Q3 2017 in Review

Secor Capital Advisors sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2017, closing a stake of 833 shares — an estimated $146K sold.

Secor Capital Advisors first reported a position in SRGA in Q2 2015 and held it in 9 quarters. The position peaked at $389K in Q2 2016. 103 funds tracked by Wall St. Rank hold SRGA as of Q3 2017.

  • Secor Capital Advisors reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Secor Capital Advisors sold 833 Surgalign Holdings, Inc. Common Stock shares in Q3 2017, an estimated $146K.
  • Secor Capital Advisors first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2015 and held it in 9 quarters.
  • Secor Capital Advisors's Surgalign Holdings, Inc. Common Stock position peaked at $389K in Q2 2016.
  • 103 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2017.

Based on Secor Capital Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.